Wei Chen

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Chemical reviews

Journal of the American Chemical Society

Nanoscale

Proceedings of the National Academy of Sciences of the United States of America

Brigham and Women's Hospital, Harvard Medical School

University of California, Los Angeles (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital, Harvard Medical School Jul 13 2020

United States

Postdoctoral Research Fellow :: Center for Nanomedicine

University of California Los Angeles Oct 01 2019 - Mar 31 2020

United States

Research Associate :: Chemistry and Biochemistry

University of California Los Angeles

United States

Graduate Student Researcher :: Chemistry & Biochemistry

University of California Los Angeles

United States

Teaching Assistant :: Chemistry & Biochemistry

Education History

University of California, Los Angeles

United States

PHD :: Chemistry & Biochemistry

National Taiwan University

Taiwan

MSC :: Chemistry

National Taiwan University

Taiwan

BSC :: Chemistry

Publications

Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao
Chemically Modified Platforms for Better RNA Therapeutics. Chemical reviews 124 (3) (2024)
Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao
Chemically Modified Platforms for Better RNA Therapeutics. Chemical reviews 124 (3) (2024)
Yesi Shi, Xueyan Zhen, Yiming Zhang, Yong-Jiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao
Correction to Chemically Modified Platforms for Better RNA Therapeutics. Chemical reviews 124 (10) (2024)
Muhammad Muzamil Khan, Yongjiang Li, Zhuoming Zhou, Abigale Ni, Qimanguli Saiding, Duotian Qin, Wei Tao, Wei Chen
Macrophage-modulating nanomedicine for cancer immunotherapy. Nanoscale (2024)
Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao
Chemically Modified Platforms for Better RNA Therapeutics. Chemical reviews 124 (3) (2024)
Muhammad Muzamil Khan, Yongjiang Li, Zhuoming Zhou, Abigale Ni, Qimanguli Saiding, Duotian Qin, Wei Tao, Wei Chen
Macrophage-modulating nanomedicine for cancer immunotherapy. Nanoscale 16 (15) (2024)
Muhammad Muzamil Khan, Yongjiang Li, Zhuoming Zhou, Abigale Ni, Qimanguli Saiding, Duotian Qin, Wei Tao, Wei Chen
Macrophage-modulating nanomedicine for cancer immunotherapy. Nanoscale 16 (15) (2024)
Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao
Chemically Modified Platforms for Better RNA Therapeutics. Chemical reviews 124 (3) (2024)
Yesi Shi, Xueyan Zhen, Yiming Zhang, Yong-Jiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao
Correction to Chemically Modified Platforms for Better RNA Therapeutics. Chemical reviews (2024)
Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao
Chemically Modified Platforms for Better RNA Therapeutics. Chemical reviews (2024)
Zhongshan He, Wei Chen, Kuan Hu, Yaoyao Luo, Wanqin Zeng, Xi He, Tingting Li, Jiang Ouyang, Yong-Jiang Li, Lin Xie, Yiding Zhang, Qin Xu, Shuping Yang, Mengran Guo, Wei Zou, Yanfei Li, Lingjing Huang, Lu Chen, Xingcai Zhang, Qimanguli Saiding, Rui Wang, Ming-Rong Zhang, Na Kong, Tian Xie, Xiangrong Song, Wei Tao
Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment. Nature nanotechnology (2024)
Zhongmin Tang, Xinru You, Yufen Xiao, Wei Chen, Yongjiang Li, Xiangang Huang, Haijun Liu, Fan Xiao, Chuang Liu, Seyoung Koo, Na Kong, Wei Tao
Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection. Proceedings of the National Academy of Sciences of the United States of America 120 (44) (2023)
Siyue Ma, Ji Hyeon Kim, Wei Chen, Lu Li, Jieun Lee, Junlian Xue, Yuxia Liu, Guang Chen, Bo Tang, Wei Tao, Jong Seung Kim
Cancer Cell-Specific Fluorescent Prodrug Delivery Platforms. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Jiang Ouyang, Bo Deng, Binhua Zou, Yongjiang Li, Qingyue Bu, Yuan Tian, Mingkai Chen, Wei Chen, Na Kong, Tianfeng Chen, Wei Tao
Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota. Journal of the American Chemical Society (2023)
Liu Yu, Mian Yu, Wei Chen, Shengjie Sun, Wenxin Huang, Tianqi Wang, Zhangwen Peng, Zewen Luo, Yixuan Fang, Yongjiang Li, Yang Deng, Meiying Wu, Wei Tao
In Situ Separable Nanovaccines with Stealthy Bioadhesive Capability for Durable Cancer Immunotherapy. Journal of the American Chemical Society (2023)
Danni Zhong, Dongxiao Zhang, Wei Chen, Jian He, Chaojie Ren, Xingcai Zhang, Na Kong, Wei Tao, Min Zhou
Orally deliverable strategy based on microalgal biomass for intestinal disease treatment. Science advances 7 (48) (2021)
Liping Ruan, Wei Chen, Ruining Wang, Jie Lu, Jeffrey I Zink
Magnetically Stimulated Drug Release Using Nanoparticles Capped by Self-Assembling Peptides. ACS applied materials & interfaces 11 (47) (2019)
Chi-An Cheng, Wei Chen, Le Zhang, Holden H Wu, Jeffrey I Zink
A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose. Journal of the American Chemical Society 141 (44) (2019)
Wei Chen, Chi-An Cheng, Emily D Cosco, Shyam Ramakrishnan, Jakob G P Lingg, Oliver T Bruns, Jeffrey I Zink, Ellen M Sletten
Shortwave Infrared Imaging with J-Aggregates Stabilized in Hollow Mesoporous Silica Nanoparticles. Journal of the American Chemical Society 141 (32) (2019)

Wei Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wei Chen